AH048 - High-Cost Orphan Drugs, Securing Claims Data, and More, with Dr. Eric Bricker

What better way to kick off 2025 than having Dr. Eric Bricker join us in the studio for Episode 48 of the Astonishing Healthcare podcast? Known for his entertaining and educational videos covering all sorts of hot topics in and around healthcare and employer/employee benefits, Dr. Bricker and host Justin Venneri discuss the issues of high-cost drugs and access to claims data - two topics he recently covered on AHealthcareZ - Healthcare Finance Explained - that should be top of mind for plan sponsors this year as pharmacy costs continue to rise.Dr. Bricker shares several ways employers, depending on their size and risk tolerance, may be able to navigate the challenge of rising pharmaceutical costs for orphan and other expensive drugs - including GLP-1s. He also explains how the RFP process can be used to secure the plan's claim data, which is necessary to meet fiduciary obligations.While every plan is unique, most plan sponsors face similar challenges that the traditional PBM model isn't flexible or aligned enough to solve. Dr. Bricker is astonished by the complacency out there, but he does see the potential for an acceleration in the pace of change this year and next... tune in to hear why, and check out the links below for more information!AHealthcareZ Reference VideosHigh Cost Orphan Disease Drugs ExplainedDo Employers Own Their Claims Data? It's Complicated.Related ContentReplay - Cracking the Code: Unraveling Specialty Drug Costs & PBM ProfitsHow to Manage Pharmacy Benefit Spend in a GLP-1 WorldAH030 - Plan Sponsors Need a Source of Truth; Get Your Data Now & Find It, with Jeff HoganPlease visit Capital Rx Insights for more information, including this episode's transcript!